GLYDO 20 mg/ml, gel in a pre-filled syringe 10 syringes of 11 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Gel10 syringes of 11 mlintravésicale;rectale;urétrale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLYDO 20 mg/mL, gel en seringue préremplie
- Pharmaceutical form
- gel
- Route of administration
- intravésicale;rectale;urétrale
- Presentation description
- 10 seringues préremplies polypropylène de 11 mL
- Marketing authorisation holder
- FARCO PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66959529CIP73024638CIP133400930246382Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNE MONOHYDRATÉgel | 21,5 mg · 1 mL de gel | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREgel | 20,1 mg · 1 mL de gel | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.